Monday, February 27, 2023: Payers

Payers should be keeping a close eye on developments in the drug pipeline for Alzheimer’s disease therapies—and how the Centers for Medicare & Medicaid Services (CMS) responds to those developments, according to a new report from Optum. The report...

Monday, February 27, 2023: D.C. News

The federal government is moving to require doctors to evaluate patients in person before writing prescriptions for some controlled medications, such as Adderall and OxyContin. The Drug Enforcement Administration announced Friday that it is seeking to revert rule...